Germany considers wider use of DNA evidence in criminal cases
By Nature
| 03. 27. 2017
Behind closed doors this week, the German federal justice ministry has been discussing whether to hand police a powerful new tool involving the analysis of DNA samples. The debate is a direct consequence of the rape and murder of a medical student in Freiburg last October.
Two months later the crime became a cause célèbre: the police arrested and charged a young refugee from Afghanistan — and public fears over the million or so refugees who have arrived in Germany in the past few years erupted. Among the political responses, Freiburg’s home state of Baden-Württemberg proposed new legislation to the federal parliament to extend the ways in which police can use genetic analysis.
Wider use of genetic analysis is something that German police and forensic scientists have long wanted. Yet it is unfortunate that in a country with some 1,600 murders every year, it had to be one involving a refugee that finally sparked the proposal. And it would be more unfortunate if the political pressure to push legislation through did not allow the time needed to create a law that is...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
